Transforming genetic discoveries into groundbreaking treatments
We accelerate the journey from genetic discovery to groundbreaking therapies in neurology, autoimmune diseases and inflammatory skin conditions.
- Neurology
- Dermatology
- Autoimmunity
Arctic Therapeutics is a clinical-stage biopharmaceutical company on a mission to treat and prevent some of the world’s most pressing diseases.
By utilizing genetic sequencing to analyze and map the genetic causes of diseases at a granular level, leveraging a geneology database comprising of all Icelanders from settlement, we apply our findings to develop effective treatments for patients worldwide.
Global research network
Our R&D efforts are augmented by a world-class ecosystem of leading experts, scientists, and research institutions, collaborating to drive genomics-informed breakthroughs in neurology, dermatology, immunology, and inflammation.
Cinical R&D Innovation Centre
Akureyri, Iceland
Corporate HQ at Gróska
Reykjavík, Iceland
Sanos Group
Copenhagen, Denmark
Regenold GmbH
Badenweiler, Germany
IGBMC: Institute of genetics, Molecular and Cellular Biology
Strasbourg, France
Complutense University of Madrid
Madrid, Spain
University of Florida
Gainesville, Florida, USA
Nacuity Pharmaceuticals
Fort Worth, Texas, USA
Premier Research
Morrisville, North Carolina, USA
Centre of Applied Genomics at CHOP
Philadelphia, Pennsylvania, USA
Neuroscios GmbH
Graz, Austria
* For the first indication of familial dementia (HCCAA). Phase IIa in Alzheimer’s
** For the first indication of acne vulgaris